Drug‐induced alterations of tumor necrosis factor‐mediated cytotoxicity: Discrimination of early versus late stage action
- 1 January 1990
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 42 (1), 1-12
- https://doi.org/10.1002/jcb.240420102
Abstract
The killing of L-M cells by murine tumor necrosis factor (mTNF) was investigated by a combination of drug, antiserum neutralization, and kinetic studies. Kinetic studies with 125I-mTNF showed that the bulk of association of ligand with L-M cells peaked within 2 hr and the ligand was not degraded. Cell surface receptors were depleted (down regulated) by 6 hr when death commenced. The off-rates of acid dissociabie (surface bound) and acid-indissociable (internalized) compartments were found to be 9 min and 35 hr, respectively. Nevertheless, complete cell killing required the persistent presence of mTNF for up to 20 hr. This requirement was ablated by the concomitant addition of cycloheximide. Antiserum completely inhibited cytotoxicity when it was applied up to 4 hr after mTNF, but antiserum added I hr after mTNF was not neutralizing in the presence of cydohe.ximide. Thus, the inclusion of cycloheximide temporally dissociated early events (internalization and signal transduction) from lysis. Other drugs with and without cycloheximide were found to preferentially affect either early or later aspects of cell death. Phorbol myristate acetate and the ionophore A23187 were potent inhibitors of cytotoxicity and staurosporine was a potent enhancer. These agents were more effective when added 1 hr before mTNF and cycloheximide than when added 1 hr after and likely affected early events in the cytolytic program. In contrast, chloroquine and cAMP likely affect more terminal aspects of cytotoxicity. Dibutyrylcyclic AMP, cholera, and pertussis toxins enhanced cytotoxicity. They were equipotent when added either before or after mTNF regardless of the presence of cycloheximide. Likewise, chloroquine was an equipotent inhibitor when added either before or after mTNF regardless of the presence ofcycloheximide. Agents that primarily affect association events may be more likely to impinge on other TNF-mediated activities than agents that primarily affect lysis.Keywords
This publication has 41 references indexed in Scilit:
- Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoidsBiochemical and Biophysical Research Communications, 1988
- Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators.The Journal of Experimental Medicine, 1987
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.Journal of Clinical Investigation, 1987
- Recombinant tumor necrosis factor and intepleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolismBiochemical and Biophysical Research Communications, 1987
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of CachexiaScience, 1985
- Kinetic Evidence for an Activation Step Following Binding of Human Interferonα2 to the Membrane Receptors of Daudi CellsEuropean Journal of Biochemistry, 1983